For the fifth year, the  European  course  of  ‘in  vivo  Preclinical  Assays  in  Cancer  Therapy’ is  jointly organized with the NKI in Amsterdam. This Symposium is an extensive training program designed to educate and update the biomedical research community on current  trends  and  technological  advances  in vivo  preclinical  assays  in  cancer. 

The emphasis of this course will be on the use of genetically engineered mouse models and patient-derived xenograft (PDX) models for in vivo preclinical research, but also in vitro preclinical assays employing established tumor cell lines and functional genomics approaches will be discussed.
The course will also cover the following topics: humanized mouse models, preclinical imaging, angiogenesis and metastasis in vivo, therapy resistance models and approaches, regulatory animal requirement, ethics and co-clinical trials.

More information